L Zenari
Overview
Explore the profile of L Zenari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zoppini G, Bonapace S, Bergamini C, Rossi A, Trombetta M, Lanzoni L, et al.
Nutr Metab Cardiovasc Dis
. 2016 Jun;
26(11):1026-1032.
PMID: 27352987
Background And Aims: Prognosis of type 2 diabetes is associated with the occurrence of cardiovascular diseases. Left atrial (LA) size is a predictor of outcome in several diseases, including diabetes....
2.
Zenari L, Marangoni A
Diabetes Obes Metab
. 2013 Sep;
15 Suppl 2:17-25.
PMID: 24034516
The aim of therapy in type 2 diabetes in terms of blood glucose control is to reduce to target levels HbA1c and to reduce glycaemic variability in order to avoid...
3.
Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, et al.
Diabetologia
. 2010 Apr;
53(7):1341-8.
PMID: 20369224
Aims/hypothesis: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased prevalence of chronic kidney disease (CKD) and retinopathy in patients with type 2 diabetes. Information on this issue is...
4.
Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, et al.
Diabet Med
. 2008 Jan;
25(1):45-50.
PMID: 18199131
Aims: We investigated the association of diabetic retinopathy with the risk of incident cardiovascular disease (CVD) events in a large cohort of Type 2 diabetic adults. Methods: Our study cohort...
5.
Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G
Diabet Med
. 2006 Oct;
23(11):1270-1.
PMID: 17054609
No abstract available.
6.
Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R, et al.
Diabet Med
. 2006 Apr;
23(4):403-9.
PMID: 16620269
Aims: To estimate the prevalence of cardiovascular disease (CVD) in Type 2 diabetic patients with and without non-alcoholic fatty liver disease (NAFLD), and to assess whether NAFLD is independently related...
7.
Targher G, Bertolini L, Padovani R, Poli F, Scala L, Zenari L, et al.
J Endocrinol Invest
. 2006 Mar;
29(1):55-60.
PMID: 16553034
Non-alcoholic fatty liver disease (NAFLD) is closely associated with several metabolic syndrome (MetS) features. We assessed whether NAFLD is significantly associated with carotid artery intima-media thickness (IMT), as a marker...
8.
Molon G, Targher G, Costa A, Bertolini L, Barbieri E, Zenari L
Diabet Med
. 2006 Jan;
23(2):207-10.
PMID: 16433721
Aims: Patients with a positive microvolt T-wave alternans (TWA) are at increased risk of ventricular arrhythmias and sudden cardiac death. Although Type 2 diabetes is associated with an increased risk...
9.
Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G
Diabet Med
. 2005 Sep;
22(10):1354-8.
PMID: 16176196
Aims: To compare plasma biomarkers of inflammation and endothelial dysfunction in individuals with and without non-alcoholic hepatic steatosis (HS), and to evaluate whether such differences were mediated by the adverse...
10.
Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G
Diabet Med
. 2005 Aug;
22(9):1146-50.
PMID: 16108840
Aims: To examine the association of non-alcoholic hepatic steatosis (HS) with the activity of the hypothalamo-pituitary-adrenal (HPA) axis in Type 2 diabetic individuals. Methods: The activity of the HPA axis,...